Cadian Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-130,243	Closed	-$12.6M	–	79
2014 Q4	$12.6M	Buy	130,243 +5,243	+4%	+$509K	0.32%	55
2014 Q3	$9.76M	Buy	125,000 +65,000	+108%	+$5.08M	0.26%	53
2014 Q2	$3.79M	Buy	+60,000	New	+$3.79M	0.11%	63